Related references
Note: Only part of the references are listed.Nutritional status in patients with head and neck cancer undergoing radiotherapy: a longitudinal study
Esra Citak et al.
SUPPORTIVE CARE IN CANCER (2019)
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
Hisham Mehanna et al.
LANCET (2019)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison et al.
LANCET (2019)
Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO)
Marta Maddalo et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2018)
Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy
Jennifer Faig et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
Salvage of recurrence after surgery and adjuvant therapy: A systematic review
Joseph Zenga et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2018)
Impact of aging on the risk of platinum-related renal toxicity: A systematic review and meta-analysis
Zhi-Yu Duan et al.
CANCER TREATMENT REVIEWS (2018)
Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis
Jimmy J. Caudell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer
John A. Vargo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative
Matthew C. Ward et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin
Shveta S. Motwani et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
Vanita Noronha et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review
Alessandro Guidi et al.
MEDICAL ONCOLOGY (2018)
Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab
Yungan Tao et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review
Sylvia L. Crowder et al.
JOURNAL OF CANCER SURVIVORSHIP (2018)
Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database
Dan P. Zandberg et al.
ORAL ONCOLOGY (2018)
The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma
Marc Hamoir et al.
CANCERS (2018)
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer
Michela Buglione et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial
Kevin J. Harrington et al.
LANCET ONCOLOGY (2017)
Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data
Petr Szturz et al.
ONCOLOGIST (2017)
Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1)
M. Manos et al.
ORAL ONCOLOGY (2017)
Estimating Survival After Salvage Surgery for Recurrent Oral Cavity Cancer
Samantha Tam et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2017)
Head and neck cancer: improving outcomes with a multidisciplinary approach
Cristiana Lo Nigro et al.
CANCER MANAGEMENT AND RESEARCH (2017)
The evidence on effectiveness of weekly vs triweekly cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC): a systematic review and meta-analysis
J. C. Kennetth Jacinto et al.
BRITISH JOURNAL OF RADIOLOGY (2017)
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
P. Bossi et al.
ANNALS OF ONCOLOGY (2017)
Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer
Teresa E. Brown et al.
BRITISH JOURNAL OF CANCER (2017)
Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence
Yeon Sil Kim
RADIATION ONCOLOGY JOURNAL (2017)
What is the role of postoperative re-irradiation in recurrent and second primary squamous cell cancer of head and neck? A literature review according to PICO criteria
Anna Merlotti et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers
Dirk Rades et al.
BMC CANCER (2016)
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement
Michela Buglione et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement
Michela Buglione et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study
C. M. L. Driessen et al.
EUROPEAN JOURNAL OF CANCER (2016)
Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience
Vlad C. Sandulache et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapy
Takahide Taguchi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer
Robert D. Frisina et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial
Stefano Maria Magrini et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines
H. Cocks et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2016)
Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer
Hideya Yamazaki et al.
JOURNAL OF RADIATION RESEARCH (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review
Myung-Ju Ahn et al.
ORAL ONCOLOGY (2016)
Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials
Wilfried Budach et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas
Jantien Hoek et al.
CANCERS (2016)
Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta-analysis
E. R. Young et al.
CLINICAL OTOLARYNGOLOGY (2015)
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors
Michela Buglione et al.
TUMORI (2015)
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors
Michela Buglione et al.
TUMORI (2015)
Local ablative treatments of oligometastases from head and neck carcinomas
C. Florescu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Salvage surgery for head and neck cancer: a plea for better definitions
Alvaro Sanabria et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2014)
Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer
Ezra E. W. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The oligometastatic state-separating truth from wishful thinking
David A. Palma et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy
J. A. E. Langius et al.
BRITISH JOURNAL OF CANCER (2013)
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studies
Lisa Licitra et al.
EUROPEAN JOURNAL OF CANCER (2013)
Toxicity and outcomes in combined modality treatment of head and neck squamous cell carcinoma: cisplatin versus cetuximab
Allison Y. Ye et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2013)
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
Arlene A. Forastiere et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
Robert Haddad et al.
LANCET ONCOLOGY (2013)
Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer
Eric F. Lartigau et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Pretreatment weight status and weight loss among head and neck cancer patients receiving definitive concurrent chemoradiation therapy: implications for nutrition integrated treatment pathways
Mary E. Platek et al.
SUPPORTIVE CARE IN CANCER (2013)
Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study
Michael T. Milano et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: A meta-analysis
Jie Ma et al.
ORAL ONCOLOGY (2012)
Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience
Alexandra D. Jensen et al.
HEAD & NECK ONCOLOGY (2010)
Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy
Giorgio Capuano et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2008)
Randomized Trial of Postoperative Reirradiation Combined With Chemotherapy After Salvage Surgery Compared With Salvage Surgery Alone in Head and Neck Carcinoma
Francois Janot et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
DJ Adelstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Importance of comorbidity in head and neck cancer
JF Piccirillo
LARYNGOSCOPE (2000)
Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: When do the ends justify the means?
WJ Goodwin
LARYNGOSCOPE (2000)
Share Paper
